Dirk Vordermark
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer, Hypoxia, and Metabolism 27
- Oncology 51
- Cancer survivorship and care 12
- Co-authors
- Michael P. Flentje (46 shared papers)Matthias Bache (46 shared papers)Matthias Kappler (26 shared papers)Harun Muayad Said (14 shared papers)Kurt Baier (12 shared papers)Oliver Kölbl (11 shared papers)Astrid Katzer (11 shared papers)Matthias Gückenberger (12 shared papers)
- Journals
- Strahlentherapie und Onkologie (36 papers)Radiation Oncology (19 papers)International Journal of Radiation Oncology*Biology*Physics (18 papers)BMC Cancer (13 papers)Radiotherapy and Oncology (12 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Dirk Vordermark
234 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 143
- Cancer Research 1.0k
- Genetics 501
- Radiation 399
- Otorhinolaryngology 141
- Oncology 758
Countries citing papers authored by Dirk Vordermark
This map shows the geographic impact of Dirk Vordermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Vordermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Vordermark more than expected).
Fields of papers citing papers by Dirk Vordermark
This network shows the impact of papers produced by Dirk Vordermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Vordermark. The network helps show where Dirk Vordermark may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Vordermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 248 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 179 | |
| 2 | 2006 | 158 | |
| 3 | 2005 | 135 | |
| 4 | 2009 | 132 | |
| 5 | Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. | 2000 | 118 |
| 6 | 2003 | 115 | |
| 7 | 2001 | 97 | |
| 8 | 2014 | 91 | |
| 9 | 2010 | 90 | |
| 10 | 2016 | 82 | |
| 11 | 1999 | 80 | |
| 12 | 2008 | 78 | |
| 13 | 2007 | 78 | |
| 14 | 2007 | 77 | |
| 15 | 2005 | 70 | |
| 16 | 2015 | 67 | |
| 17 | 2014 | 65 | |
| 18 | 2007 | 64 | |
| 19 | 2005 | 63 | |
| 20 | 2007 | 62 |
About Dirk Vordermark
Dirk Vordermark is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiation and Genetics, having authored 248 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (27 papers), Advanced Radiotherapy Techniques (19 papers), Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (13 papers), Cancer survivorship and care (12 papers), Endometrial and Cervical Cancer Treatments (11 papers), Bone and Dental Protein Studies (11 papers) and Enzyme function and inhibition (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Genetics (501 citations), Radiation (399 citations), Otorhinolaryngology (141 citations) and Oncology (758 citations). Dirk Vordermark has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Michael P. Flentje, Matthias Bache, Matthias Kappler, Harun Muayad Said, Kurt Baier, Oliver Kölbl, Astrid Katzer, Matthias Gückenberger, Henri Wichmann and J. Martin Brown. Their work appears in journals such as Strahlentherapie und Onkologie, Radiation Oncology, International Journal of Radiation Oncology*Biology*Physics, BMC Cancer and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.